White House’s new high-risk life sciences policy calls for monitoring AI dangers
“The White House Office of Science and Technology Policy (OSTP) will convene an interagency group to monitor advancements at the intersection of biological sciences and artificial intelligence, including in silico life sciences research,” the guidance says.
Record details
Published: 29 July 2026
Source: NextGov/FCW
Category: News
Topics: Regulation · Biotech
Retrieved: 30 July 2026
Related evidence
These records share source-supplied organisations, an exact publisher byline, automatic topics or regions. The reason is shown on every link; related does not mean supporting, agreeing with or verifying this record.
Senate’s short-term funding bill provides temporary extensions for TMF, cyber data-sharing law
NextGov/FCW · 10 August 2026
Acquisition overhaul is providing needed ‘discretion’ for tech adoption, procurement chief says
NextGov/FCW · 23 July 2026
Seizing the digital advantage at DOD
NextGov/FCW · 8 July 2026
Navigating the Global Regulatory Landscape for Exosome-Based Therapeutics: Challenges, Strategies, and Future Directions
OpenAlex · 30 July 2025
Closing the data loop in AI-driven drug discovery
MIT Technology Review · 27 July 2026
Possible Is Not Plausible: How Nightmare Scenarios Hijack Unconventional Weapons Policy
War on the Rocks · 3 August 2026
How to cite this record
ethics.ai (29 July 2026), “White House’s new high-risk life sciences policy calls for monitoring AI dangers,” evidence record 14719, https://ethics.ai/record/14719 (originally published by NextGov/FCW).
Use and limitations
This page is a stable index and citation surface for a source record. ethics.ai did not author the underlying report and has not independently verified every claim. Automatic topics may be imperfect. For consequential use, quote and cite the original publisher.